Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey
Ola Landgren(University of Miami Health System), S. Vincent Rajkumar(WinnMed), Terry M. Therneau(Mayo Clinic), Malin Hultcrantz(United States Fish and Wildlife Service), Neil E. Caporaso(Unknown), Robert A. Kyle(Mayo Clinic), Shaji Kumar(Mayo Clinic), Kazunori Murata(Memorial Sloan Kettering Cancer Center), Rene Costello(National Institutes of Health), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Neha Korde(United States Fish and Wildlife Service), Barry I. Graubard(National Cancer Institute), James R. Cerhan(Mayo Clinic), Angela Dispenzieri(Mayo Clinic), J A Katzmann(Mayo Clinic), Dirk R. Larson(Mayo Clinic in Florida)
Cited by 116
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k